Last reviewed · How we verify
NCT05316350
Withings ECG-app Study
NA trial testing Electrocardiogram recording in Atrial Fibrillation in 685 participants. Completed in 15 August 2023.
15 August 2023
Quick facts
| Lead sponsor | Withings |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 685 |
| Start date | 15 July 2022 |
| Primary completion | 15 August 2023 |
| Estimated completion | 15 August 2023 |
| Sites | 10 locations across France, United States |
Drugs / interventions tested
- Electrocardiogram recording
- Electrocardiogram recording
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
Withings — full company profile →
Who can join
22 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the performance of Withings HWA10 with embedded Withings ECG-app in the automatic detection of atrial fibrillation
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05316350
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electrocardiogram recording
Trials testing the same drug.
- NCT06622265 — WHOOP ECG Software Performance Assessment Study · completed
- NCT04715555 — A Study of the Acceptability and Performance of Wearables for Atrial Fibrillation Screening in Older Adults · active not recruiting
- NCT05316337 — Withings ECG-Monitor Study · NA · completed
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Withings trials
Trials by the same sponsor.
- NCT06957847 — Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP) · NA · completed
- NCT06692413 — Withings Devices Follow-up Study - Hypertension · withdrawn
- NCT06351761 — WIBOFA - Validation of SCT02 With ECG-App for Detection of AF · NA · completed
- NCT05823025 — Withings Study to Analyze the Accuracy of Pulse Wave Velocity Measurement With Bathroom Scales (WIVOP-Scales) · active not recruiting
- NCT05316337 — Withings ECG-Monitor Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05316350 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Withings
- Last refreshed: 20 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05316350.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing